Pro Medicus Limited ( (PMCUF) ) has released its Q4 earnings. Here is a breakdown of the information Pro Medicus Limited presented to its investors.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Pro Medicus Limited is a leading healthcare informatics company specializing in medical imaging software and services for hospitals and healthcare groups across Australia, Europe, and North America. The company has reported a strong financial performance for the year ended June 30, 2025, with a 31.9% increase in revenue to $213 million and a 39.2% rise in profit after tax to $115.2 million. Key highlights include the acquisition of seven new long-term contracts in North America, a robust pipeline of opportunities, and continued expansion in cloud-based solutions. Pro Medicus remains debt-free with strong cash reserves, supporting a 37.5% increase in declared dividends to 55 cents per share. The company is well-positioned for future growth, driven by its innovative Visage 7 platform and strategic focus on cloud deployment and AI integration. Looking ahead, Pro Medicus aims to capitalize on the growing demand for cloud-based healthcare solutions and maintain its leadership in the medical imaging sector.